Effects of imatinib mesylate on adenoid cystic carcinomas

Anticancer Research

Volumn 25, Issue 5, 2005, Pages 3659-3664

  Ochel, Hans Joachim ^a   Gademann, Günther ^a   Röcken, Christoph ^a   Wördehoff, Herbert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Adenoid cystic carcinoma; Imatinib; Salivary gland

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; IMATINIB; PACLITAXEL; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; STEM CELL FACTOR RECEPTOR;

ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RARE DISEASE; RELAPSE; REMISSION; RHABDOMYOLYSIS; SALIVARY GLAND TUMOR;

ADULT; ANTINEOPLASTIC AGENTS; CARCINOMA, ADENOID CYSTIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES;

EID: 23344445839     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Sessions RB, Harrison LB and Forastiere AA: Tumors of the salivary glands and paragangliomas. In: Cancer Principles and Practice of Oncology, Vol. 1. DeVita VT, Hellman S and Rosenberg SA (eds.). Philadelphia, Lippincott, pp. 886-906, 2001.
2. Silverman DA, Carlson TP, Khuntia D, Bergstrom RT, Saxton J and Esclamado RM: Role for postoperative radiation therapy in adenoid cystic carcinoma of the head and neck. Laryngoscope 114: 1194-1199, 2004.
3. Frierson HF, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, Cheng J, Saku T, Moskaluk CA and Hampton GM: Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic cacinoma. Am J Pathol 161: 1315-1323, 2002.
4. Verwej J, de Mulder PH, de Graeff A, Vermorken JB, Wildiers J, Kerger J, Schornagel J, Cognetti F, Kirkpatrick A, Sahmoud T and Lefebvre JL: Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cooperative Group. Ann Oncol 7: 867-869, 1996.
5. Hill ME, Constenla DO, A'Hern RP, Henk JM, Rhys-Evans P, Breach N, Archer D and Gore ME: Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma. Oral Oncol 33: 275-278, 1997.
6. Airoldi M, Fornari G, Pedani F, Marchionatti S, Gabriele P, Succo G and Bumma C: Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anticancer Res 20: 3781-3783, 2000
7. Airoldi M, Pedani F, Succo G, Gabriele AM, Ragona R, Marchionatti S and Bumma C: Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies. Cancer 91: 541-547, 2001.
8. Holst VA, Marshall CE, Moskaluk CA and Frierson HFJ: KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol 12: 956-960, 1999.
9. Jeng YM, Lin CY and Hsu HC: Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett 54: 107-111, 2000.
10. Edwards PC, Bhuiya T and Kelsch RD: C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 586-593, 2003.
11. Penner CR, Folpe AL and Budnick SD: C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Mod Pathol 15: 687-691, 2002.
12. Hotte SJ, Winquist EW, Lamont E, MacKenzie M, Vokes E, Chen EX, Brown S, Pond GR, Murgo A and Siu LL: Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study. J Clin Oncol 23: 585-590, 2005.
13. Alcedo JC, Fabrega JM, Arosemena JR and Urrutia A: Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: reports of two successfully treated cases. Head Neck 26: 829-831, 2004.
14. Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen C-J, Van den Abbeele AD, Druker BJ, Kiese B, Eisenberg B, Roberts PJ, Singer S, Fletcher CDM, Silberman S, Dimitrijevic S and Fletcher JA: Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21: 4342-4349, 2003.
15. Went PT, Dirnhofer S, Bundi M, Mirlacher M, Schraml P, Mangialaio S, Dimitrijevic S, Kononen J, Lugli A, Simon R and Sauter G: Prevalence of KIT expression in human tumors. J Clin Oncol 22: 4514-4522, 2004.
16. Johnson BE, Fischer T, Fischer B, Dunlop D, Rischin D, Silberman S, Kowalski MO, Sayles D, Dimitrijevic S, Fletcher C, Hornick J, Salgia R and Le Chevalier T: Phase II study of imatinib in patients with small cell lung cancer. Clin Cancer Res 9: 5880-5887, 2003.
17. Gambacorti-Passerini C, Piazza R, Tornaghi L, Pilotti S and Pogliani E: Development of c-Kit-expressing small-cell lung cancer in a chronic myeloid leukemia patient during imatinib treatment. J Natl Cancer Inst 96: 1723-1724, 2004.